Document Detail

Biochemical and neurohormonal responses to the introduction of a lacto-ovovegetarian diet.
MedLine Citation:
PMID:  8228209     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To assess the mechanisms of the blood pressure-lowering effect of a vegetarian diet in the early and later stages of dietary intervention. DESIGN: After 2 weeks without intervention (baseline), 20 normotensive men were matched for age and body mass index and randomly allocated to an omnivorous (control) or a lacto-ovovegetarian diet for 6 weeks in a parallel trial. METHODS: Ambulatory blood pressures were recorded between 0800 and 1700 h on alternate days during the first week of intervention, twice in the second week and weekly thereafter. Blood samples collected after a standard breakfast were analysed for plasma noradrenaline, adrenaline, atrial natriuretic peptide (ANP), renin, aldosterone, glucose and insulin. Factor and multiple regression analyses were used to assess the association among neurohormonal factors, blood pressures and diet. Results were analysed for the first week of the diet and for the entire 6 weeks. RESULTS: Ambulatory blood pressures at work were lower on the vegetarian diet than in the controls. This blood pressure decrease was associated with a factor representing lower plasma catecholamine and renin activity levels throughout the study, and a factor representing reduced plasma glucose and insulin levels in week 1 of intervention only. Plasma ANP levels were significantly higher during week 1 of the vegetarian diet. CONCLUSIONS: A blood pressure lowering effect of a vegetarian diet during normal working activity was shown. Using factors derived from the biochemical variables, results were in keeping with the hypothesis that these effects may be mediated by reduced sympatho-adrenal activity consequent to altered glucose and insulin handling. An early increase in plasma ANP may contribute to the blood pressure reduction.
S E Sciarrone; M T Strahan; L J Beilin; V Burke; P Rogers; I L Rouse
Related Documents :
20298929 - Reverse remodeling of the atria after treatment of chronic stretch in humans: implicati...
2536599 - Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in h...
2366549 - Effects of bilateral transvenous diaphragm pacing on hemodynamic function in patients a...
22451169 - Effects of different ventilation strategies on lung injury in newborn rabbits.
2952859 - Circulating atrial natriuretic peptide (anp) and central blood volume (cbv) in cirrhosis.
19386989 - B-type natriuretic peptide 8-32, which is produced from mature bnp 1-32 by the metallop...
18596629 - Differential effects of osmotherapy on static and pulsatile intracranial pressure.
20724939 - Augmentation index and central aortic blood pressure in patients with abdominal aortic ...
16966939 - Regression of bilateral optic disc edema after discontinuation of amiodarone.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hypertension     Volume:  11     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1993-12-07     Completed Date:  1993-12-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  849-60     Citation Subset:  IM    
Department of Medicine, University of Western Australia, Perth.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / analysis
Blood Pressure*
Diet, Vegetarian*
Heart Rate
Hormones / blood*
Middle Aged
Reg. No./Substance:
0/Blood Glucose; 0/Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Amlodipine and lisinopril in combination for the treatment of essential hypertension: efficacy and p...
Next Document:  Haptoglobin polymorphism and complications in established essential arterial hypertension.